Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Cancer of the Tongue

gefitinib has been researched along with Cancer of the Tongue in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dyszkiewicz-Konwinska, M; Jodynis-Liebert, J; Jozkowiak, M; Kaczmarek, M; Kranc, W; Piotrowska-Kempisty, H; Ramlau, P; Spaczynska, J; Wierzchowski, M1
Hamakawa, H; Li, C; Mihara, M; Nakashiro, K; Shintani, S1
Jeon, NK; Kim, J; Lee, EJ; Whang, JH1

Other Studies

3 other study(ies) available for gefitinib and Cancer of the Tongue

ArticleYear
Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition.
    International journal of molecular sciences, 2021, Jun-08, Volume: 22, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Resveratrol; Tongue Neoplasms; Tumor Cells, Cultured

2021
Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells.
    Cancer letters, 2003, Nov-25, Volume: 201, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Enzyme Inhibitors; ErbB Receptors; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Gefitinib; Green Fluorescent Proteins; Integrins; Luminescent Proteins; Lymph Nodes; Lymphatic Metastasis; Mice; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Tongue Neoplasms; Tumor Cells, Cultured

2003
The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous carcinoma cells via p53 independent and MMP, uPAR dependent mechanism.
    Annals of the New York Academy of Sciences, 2007, Volume: 1095

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gefitinib; Humans; Matrix Metalloproteinases; Neoplasm Invasiveness; Protein Kinase Inhibitors; Quinazolines; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tongue Neoplasms; Tumor Suppressor Protein p53

2007